Gene Expression Profiles in Rat Liver Slices Exposed to Hepatocarcinogenic Enzyme Inducers, Peroxisome Proliferators, and 17α-Ethinylestradiol

Abstract

Transcription profiling is used as an in vivo method for predicting the mode-of-action class of nongenotoxic carcinogens. To set up a reliable in vitro short-term test system DNA microarray technology was combined with rat liver slices. Seven compounds known to act as tumor promoters were selected, which included the enzyme inducers phenobarbital, alpha-hexachlorocyclohexane, and cyproterone acetate; the peroxisome proliferators WY-14,643, dehydroepiandrosterone, and ciprofibrate; and the hormone 17alpha-ethinylestradiol. Rat liver slices were exposed to various concentrations of the compounds for 24 h. Toxicology-focused TOXaminer DNA microarrays containing approximately 1500 genes were used for generating gene expression profiles for each of the test compound. Hierarchical cluster analysis revealed that (i) gene expression profiles generated in rat liver slices in vitro were specific allowing classification of compounds with similar mode of action and (ii) expression profiles of rat liver slices exposed in vitro correlate with those induced after in vivo treatment (reported previously). Enzyme inducers and peroxisome proliferators formed two separate clusters, confirming that they act through different mechanisms. Expression profiles of the hormone 17alpha-ethinylestradiol were not similar to any of the other compounds. In conclusion, gene expression profiles induced by compounds that act via similar mechanisms showed common effects on transcription upon treatment in vivo and in rat liver slices in vitro.

Identification of consensus biomarkers for predicting non-genotoxic hepatocarcinogens

“…A2m (a 2 -macroglobulin) is a member of the thiol ester protein family whose mRNA levels in rat liver were found to be linked to acute inflammation54 and NGHC-induced tumorigenesis555657. Cxcl1 (C-X-C motif chemokine ligand 1) was found to be associated with drug-induced liver injury58, cirrhosis59, and hepatitis60.…”

Set-Based Joint Test of Interaction Between SNPs in the VEGF Pathway and Exogenous Estrogen Finds Association With Age-Related Macular Degeneration

“…42 PLCG1 has an established interaction with Ginsenoside Rg1, 46 a drug known for exerting estrogen-like activity. Also, PLCG2 interacts with dehydroepiandrosterone (DHEA), 47 a chemical precursor that is converted to estrogen, and exemestane, 48 an aromatase inhibitor that blocks estrogen synthesis. In contrast to these findings, estrogens (including BCP use) have previously been inversely associated with AMD in women.…”

PPAR-Mediated Toxicology and Applied Pharmacology

“…The hepatocarcinogenesis by PPARα activation was fully investigated over 30 years. The main target of PPARα is the liver, which induces pleiotropic impacts such as hypertrophy and hyperplasia [57,58]. These unmanaged responses cause hepatocellular carcinomas in rodents.…”